EMA
approval
· 2020-09-18
First treatment for rare metabolic disorder alkaptonuria
Summary
EMA announces the first approved treatment for alkaptonuria, a rare metabolic disorder, marking a pivotal milestone for patients affected by this condition.
Upgrade for the full analysis, importance score, and drug timeline.